Table S1. Basal characteristics and clinical outcomes of non-low skeletal muscle mass patients with and without rehabilitation.
| Variable | Rehabilitation (N=52) | Non-rehabilitation (N=43) | P |
|---|---|---|---|
| Age, years | 64.9±14.7 | 64.8±14.1 | 0.998 |
| Male | 26 (50.0) | 28 (65.1) | 0.1319 |
| BMI (kg/m2) | 23.9±3.2 | 23.4±3.5 | 0.459 |
| SMI (cm2/m2) | 54.6±12.6 | 61.1±17.2 | 0.036 |
| APACHE II | 15.5±6.3 | 14.5±7.3 | 0.507 |
| SOFA | 8.5±4.6 | 7.9±4.2 | 0.523 |
| CCI | 4.2±2.3 | 4.4±2.8 | 0.717 |
| Multiple vasopressor use | 38 (73.1) | 33 (76.7) | 0.682 |
| Renal replacement therapy | 18 (34.6) | 10 (23.3) | 0.227 |
| Lactate on admission | 2.7±4.5 | 7.1±27.9 | 0.315 |
| Infection source | |||
| Respiratory | 46 (88.5) | 35 (81.4) | 0.333 |
| Abdominal | 5 (9.6) | 4 (9.3) | 0.361 |
| Urinary tract | 11 (21.2) | 3 (7.0) | 0.025 |
| Soft tissue | 5 (9.6) | 3 (7.0) | |
| Ventilator day | 34.8±40.0 | 14.7±13.8 | 0.002 |
| Hospital stay | 60.5±53.5 | 25.2±21.3 | <0.001 |
| ICU stay | 20.9±29.2 | 13.3±21.3 | 0.119 |
| In-hospital mortality | 10 (19.2) | 14 (32.6) | 0.137 |
| Discharge to home | 33 (63.5) | 23 (53.5) | 0.325 |
| 6-month mortality | 11 (21.2) | 14 (32.6) | 0.209 |
| 1-year mortality | 15 (28.8) | 16 (37.2) | 0.387 |
Values are expressed as mean ± standard deviation or n (%). BMI, body mass index; SMI, skeletal muscle index; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; CCI, Charlson Comorbidity Index.